Le Lézard
Classified in: Health
Subjects: TDS, FVT

Bio-Ess Laboratories to Present on Increasing Antibody Titer Without Impacting Glycosylation at The Bioprocessing Summit


EWING, N.J., Aug. 17, 2017 /PRNewswire/ -- Bio-Ess Laboratories, LLC Chief Science Officer, Dr. Adam Elhofy, will be discussing mechanisms to increase antibody titer and present new data on Cell-Ess® Universal Titer Boost at the 9th annual Bioprocessing Summit in Boston, MA August 21-25.  The Bioprocessing Summit convenes more than 1,000 international bioprocess professionals to share practical solutions for today's bioprocess challenges.

Cell-Ess is the world's first universal titer boost and enhancer that works across a wide range of media systems.  Cell-Ess used as a feed improves consistency in glycan patterns while increasing protein titer by 20-50% compared to control in various previously optimized cell lines and media schemes.  The increase is observed in glass shake flasks, single-use Wave Bioreactorstm, and ambr® cell culture systems.  New data to be presented by Dr. Elhofy indicates that Cell-Ess improves glycosylation consistency and complexity in addition to improving titer.

Dr. Elhofy will discuss bioprocessing challenges and present data during his talk titled "Improved Antibody Quality and Consistency in CHO Cells Using a Novel Media Supplement" on Wednesday, August 23rd at 11:15 am.  He will also present a poster entitled "Glycolytic Complexity and Pattern Consistency can be Improved by Using a Novel Supplement and Feed" at poster #B11 on Wednesday and Thursday.  Bio-Ess Laboratories will be exhibiting Cell-Ess and the non-fixative tissue preservation media Clin-Ess® at Booth #402.

"Numerous studies by Bio-Ess and others has shown that Cell-Ess increases monoclonal antibody titer without increasing cells," says Dr. Elhofy.  "Our new data shows that Cell-Ess also improves glycosylation consistency and can increase higher order glycoforms, which is vital for companies concerned with critical quality attributes."

"The Bioprocessing Summit brings together leaders in the bioprocessing community to discuss challenges and future outlook in the production of biologics," says Allan Weber, CEO for Bio-Ess.  "We are honored to sponsor this pivotal event yet again this year and share our insights with industry leaders."

About Bio-Ess Laboratories

Bio-Ess Laboratories, LLC was formed from Essential Pharmaceuticals, LLC to focus on the research and bioprocessing industries.  Bio-Ess is the developer and provider of Cell-Ess Universal Titer Boost for bioprocessing and Clin-Ess Tissue Preservation Media for tissue preservation and transport.

For more information on Bio-Ess Laboratories, visit www.bio-ess.com or contact Denise Weber at the corporate office: 1-844-Ess-Prod Email: [email protected]

SOURCE Bio-Ess Laboratories, LLC


These press releases may also interest you

19 avr 2024
Remedium Healthcare Products is proud to announce the launch of NuVeria Labs' revolutionary Sacral Silicone Dressing, now available for purchase on Amazon, bringing advanced wound care solutions directly to consumers' doorsteps. Designed to address...

19 avr 2024
Getting specialty medications into...

19 avr 2024
Arthrex, a global leader in minimally invasive surgical technology, has once again taken home prestigious medals for product innovation at the 37th annual Edison Awards. "This product, along with our other innovations,...

19 avr 2024
Aligned with the trend of immersive water therapy in 2024, Baros Maldives' Serenity Spa stands out as an oasis of indulgent spa and beauty rituals, boasting a 50-year legacy of luxury. Nestled within a tranquil sanctuary amidst the lush Maldivian...

19 avr 2024
Oragenics, Inc. , a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it received a notice (the "Notice") from the NYSE American LLC (the "NYSE American") dated April...

19 avr 2024
Building on a successful phase one in which STChealth proved that the Universal Patient Identifier (UPI)?powered by Experian Health's Universal Identity Manager (UIM) and NCPDP Standardstm?can accurately identify patients across multiple datasets in...



News published on and distributed by: